Growth Metrics

Maravai Lifesciences Holdings (MRVI) Deferred Taxes (2020 - 2024)

Maravai Lifesciences Holdings has reported Deferred Taxes over the past 5 years, most recently at $11000.0 for Q4 2024.

  • Quarterly results put Deferred Taxes at $11000.0 for Q4 2024, down 100.0% from a year ago — trailing twelve months through Dec 2024 was $11000.0 (down 100.0% YoY), and the annual figure for FY2025 was -$20000.0, down 281.82%.
  • Deferred Taxes for Q4 2024 was $11000.0 at Maravai Lifesciences Holdings, down from $764.8 million in the prior quarter.
  • Over the last five years, Deferred Taxes for MRVI hit a ceiling of $764.8 million in Q4 2023 and a floor of -$5.5 million in Q3 2023.
  • Median Deferred Taxes over the past 5 years was $6.7 million (2021), compared with a mean of $52.4 million.
  • Biggest five-year swings in Deferred Taxes: skyrocketed 1122800.0% in 2021 and later crashed 159.91% in 2023.
  • Maravai Lifesciences Holdings' Deferred Taxes stood at -$4.2 million in 2020, then soared by 516.95% to $17.5 million in 2021, then plummeted by 59.86% to $7.0 million in 2022, then skyrocketed by 10807.86% to $764.8 million in 2023, then tumbled by 100.0% to $11000.0 in 2024.
  • The last three reported values for Deferred Taxes were $11000.0 (Q4 2024), $764.8 million (Q4 2023), and -$5.5 million (Q3 2023) per Business Quant data.